Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders for Inhibrx Biosciences, Inc., held on May 28, 2025. The meeting was conducted virtually. As of the record date of April 1, 2025, the company had 14,475,904 shares of common stock issued and outstanding eligible to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
A quorum of 11,493,284 shares (approximately 79% of eligible shares) was present virtually or by proxy. The following actions were taken:
- Proposal 1: Election of Class I Directors
- Jon Faiz Kayyem, Ph.D.: Elected with 8,077,611 votes for, 31,060 votes withheld, and 3,384,613 broker non-votes.
- Kristiina Vuori, M.D., Ph.D.: Elected with 6,494,317 votes for, 1,614,354 votes withheld, and 3,384,613 broker non-votes.
- Both directors will serve until the 2028 Annual Meeting.
- Proposal 2: Ratification of Independent Auditor
- BDO USA, P.C. was ratified as the independent registered public accounting firm for the year ending December 31, 2025.
- Votes: 11,463,328 For, 2,918 Against, 27,038 Abstained, 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. Detailed descriptions of the proposals are referenced in the definitive proxy statement filed on April 16, 2025.
Key Facts for Investor Verification
- Verify the specific terms of the director elections and the tenure of the newly elected Class I Directors.
- Confirm the engagement terms and scope of work for BDO USA, P.C. as the independent auditor.
- Review the definitive proxy statement filed on April 16, 2025, for detailed background on the proposals and any related governance discussions.
- Note the significant number of broker non-votes (3,384,613) on the director election, indicating shares held by brokers that were not voted on this matter.